Multi‐Omics Analysis of TYMS as a Prognostic Biomarker and Therapeutic Target for Lung Adenocarcinoma

ABSTRACT Lung adenocarcinoma (LUAD) is a predominant form of lung cancer with poor prognosis due to early diagnosis challenges and treatment resistance. Thymidylate synthetase (TYMS), a key enzyme in DNA synthesis, has been associated with poor prognosis in multiple cancers, yet its multi‐omics char...

Description complète

Détails bibliographiques

Auteurs principaux:	Hansen Shi, Peijun Zhang, Jiayi Chen, Hua Li, Xiaohuai Zhang, Biyun zeng, Tiancai Liu, Tao Zeng
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2026-04-01
Collection:	Cancer Medicine
Sujets:	bioinformatics biomarkers LUAD multi‐omics analysis prognostic markers therapeutic targets
Accès en ligne:	https://doi.org/10.1002/cam4.71814
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!